What Is a 510(k)? FDA 510(k) Clearance Explained for Device Makers
2026-08-21 · Caduvo Team
A 510(k) is a premarket notification that demonstrates your device is substantially equivalent to a predicate. Learn what it is, who needs it, what a submission contains, realistic timelines, and the most common pitfalls that trigger Additional Information requests.
You don’t need FDA approval for most Class II devices. You need clearance—and that’s a different process entirely. The 510(k) pathway is a premarket notification, not an application for approval. It tells the FDA that your device is substantially equivalent to a legally marketed device that doesn’t require a PMA. If you’re a founder or regulatory lead staring down a first submission, understanding exactly what a 510(k) is—and what it isn’t—can save months of rework and a lot of wasted money.
What Is a 510(k)?
A 510(k) is a premarket notification submitted to the FDA under section 510(k) of the Food, Drug, and Cosmetic Act. The goal is to demonstrate that your device is substantially equivalent to a predicate device—one that is already legally marketed in the U.S. The FDA uses the term “clearance,” not “approval.” Clearance means the agency found your device to be as safe and effective as the predicate and does not present new questions of safety or effectiveness. It does not mean the FDA independently reviewed your device’s safety and efficacy from scratch, as it would in a PMA.
Substantial equivalence has two legs: the new device must have the same intended use as the predicate, and any technological differences must not raise different questions of safety or effectiveness. You’ll need to provide performance data, such as bench testing, biocompatibility, or clinical data, to bridge any differences. Choosing the right predicate is the single most consequential decision you’ll make. The wrong one can trigger a “Not Substantially Equivalent” (NSE) determination and force you to start over. For a step-by-step guide on predicate selection, see Predicate Devices: How to Find and Choose One for Your 510(k).
Who Needs a 510(k)?
Most Class II devices require a 510(k). Some Class I devices are also 510(k)-exempt unless they fall into a non-exempt category. Class III devices generally require a PMA, but a few legacy Class III devices still go through the 510(k) route until the FDA calls for PMAs. If you don’t have a predicate, you can’t use a 510(k). The De Novo pathway exists for novel low-to-moderate-risk devices without a predicate. If you’re unsure about your device’s classification, refer to the FDA product classification database or read FDA Medical Device Classification: Class I, II, and III Explained.
Common exemptions: many Class I and a limited set of Class II devices are exempt from 510(k) by regulation. But exemptions are narrow. A Class II device that is exempt still needs a 510(k) if it differs from the exempt device in a way that could affect safety or effectiveness. Check 21 CFR Parts 862–892 for the exact listing.
What Goes Into a 510(k) Submission?
A complete 510(k) submission is a package of documents, not a single form. While the exact contents depend on the device, every submission includes:
- Medical Device User Fee Cover Sheet (Form FDA 3601) – confirms you’ve paid the MDUFA user fee.
- 510(k) Summary or 510(k) Statement – a summary of the substantial equivalence determination or a statement that the information will be made available within 30 days.
- Truthful and Accurate Statement – a signed certification that all information is truthful and accurate.
- Indications for Use Statement (Form FDA 3881) – the exact wording of what the device is for, which must match the predicate’s indications or be supported by data.
- Device Description – engineering drawings, components, materials, principles of operation.
- Substantial Equivalence Discussion – a side-by-side comparison of your device and the predicate, including intended use, technological characteristics, and performance testing.
- Performance Testing Data – bench testing, biocompatibility (ISO 10993), electrical safety (IEC 60601), software documentation (IEC 62304), sterilization validation, and any clinical data if needed.
- Labeling – proposed labels, instructions for use, and patient-facing materials.
Software-driven devices must include a software description and cybersecurity documentation. Devices with wireless capabilities need additional RF testing. The FDA’s Refuse to Accept (RTA) policy checks for completeness before the substantive review begins. An incomplete package gets rejected outright, clock restarts.
Timelines, Costs, and Realistic Review Hurdles
The FDA has a statutory 90-day review clock for a 510(k) submission. In practice, the clock stops when the agency issues an Additional Information (AI) request. The total time from submission to clearance often runs 6–9 months, sometimes longer if multiple rounds of questions occur.
The review process follows a set order:
- Acceptance Review (15 days) – FDA checks for administrative completeness.
- Substantive Review (60 days) – lead reviewer evaluates the submission.
- Interactive Review – FDA may request additional information, and the clock stops. You respond; the clock resumes.
- Final Decision – MDUFA IV goal is to issue a decision on 90% of submissions within 90 FDA days, but the total elapsed time is longer due to hold periods.
Costs break down into user fees, testing, and preparing the submission. The standard 510(k) fee for FY2024 is $21,870. Small businesses with FDA certification get a reduced fee of $5,468. The total cost of a 510(k)—including testing, regulatory writing, and consulting—typically ranges from $30,000 to $150,000 for a straightforward device. Complex devices with clinical data can easily exceed $500,000.
Common Reasons for Additional Information Requests
AI letters are the single biggest time sink. The most frequent triggers:
- Inadequate predicate comparison – Vague or incomplete side-by-side tables. The FDA expects you to quantify every difference, not just say “similar.”
- Missing or insufficient performance data – Biocompatibility testing that doesn’t follow the correct ISO 10993 endpoints, or electrical safety reports that don’t cover all operating modes.
- Human factors gaps – For devices used by laypeople or in home settings, the FDA expects a usability study. If you skip it, expect a hold.
- Labeling inconsistencies – The indications for use on Form FDA 3881 don’t match the instructions for use. Even a single word change can trigger a question.
- Software documentation issues – Failing to provide the level of documentation required by the FDA’s software premarket guidance, including architecture diagrams and hazard analysis.
Each AI letter resets the clock and adds weeks or months. The best defense is a pre-submission meeting (Q-Sub) where you can get the FDA’s feedback on your testing plan and predicate selection before you submit.
Actionable Takeaways
- Use the 510(k) pathway only if you have a legally marketed predicate. If you don’t, explore the De Novo pathway.
- Nail the predicate selection before you spend a dime on testing. A weak predicate leads to an NSE.
- Budget for a total timeline of 6–12 months, not 90 days.
- Submit a pre-submission to the FDA to align on testing requirements and reduce AI requests.
- Double-check your Indications for Use form against your labeling. Word-for-word.
Caduvo’s platform helps 510(k) teams identify predicates, assess freedom-to-operate, and map reimbursement pathways early—so you don’t build a device that clears the FDA but can’t get paid.